Bill Miller
Miller Value Partners
Bill Miller Celgene Corp stake
total: 463
Miller Value Partners CELG trades
- Total transactions:
- 7
- New positions:
- 1
- Sold out:
- 1
- Added:
- 4
- Reduced:
- 1
- Held since:
- 2017 Q2
- Held for:
- 8 quarters
- Latest activity:
- 2019 Q2
According to 2026 Q2 report, Bill Miller doesn't hold any Celgene Corp (CELG) shares. To date, the estimated cost basis is nearly $85.9 for "buy" trades and estimated average "sell" price is $94.34. Miller Value Partners first purchased CELG in 2017 Q2, initially acquiring 2,200 shares. Since the initial investment in Celgene Corp (CELG), Miller Value Partners has made 6 more transactions.
When did Bill Miller sell Celgene Corp (CELG)?
Bill Miller sold off the entire Celgene Corp (CELG) position in 2019 Q2.
When did Bill Miller buy Celgene Corp (CELG)?
Bill Miller first invested in Celgene Corp (CELG) in 2017 Q2 at the reported quarter-end price of $130.00 per share.
What's the cost basis of Miller Value Partners's CELG stake?
The estimated cost basis for Celgene Corp (CELG) stake is around $85.90 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $85.90
- Weighted AVG sell price:
- $94.34
Bill Miller's historical trades in Celgene Corp
7 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2019 Q2
|
0.00%
|
$94.34
|
-100% (-423,255)
|
|||
|
2019 Q1
|
1.59%
|
$94.34
|
-49.38% (-412,940)
|
|||
|
2018 Q4
|
2.44%
|
$64.09
|
+0.51% (+4,250)
|
|||
|
2018 Q3
|
2.43%
|
$89.49
|
+19.04% (+133,040)
|
|||
|
2018 Q2
|
2.09%
|
$79.42
|
+68.80% (+284,850)
|
|||
|
2018 Q1
|
1.58%
|
$89.21
|
+18,720.68% (+411,855)
|
|||
|
2017 Q2
|
0.01%
|
$130.00
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.